James M Rae

5PUBLICATIONS
24CO-AUTHORS
Predictive and prognostic markersPharmacogenomicsOncology and carcinogenesis not elsewhere classifiedMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 02, 2024
Development and Validation of the RSClinN+ Tool to Predict Prognosis and Chemotherapy Benefit for Hormone Receptor-Positive, Node-Positive Breast Cancer.

Lajos Pusztai, Jess R Hoag, Kathy S Albain

|Aug 24, 2023
Effects of CYP3A4 and CYP2C9 genotype on systemic anastrozole and fulvestrant concentrations in SWOG S0226.

Delaney V Rutherford, Sarah Medley, Nicholas C Henderson

|Jan 17, 2023
Evaluation of the Sensitivity to Endocrine Therapy Index and 21-Gene Breast Recurrence Score in the SWOG S8814 Trial.

Corey W Speers, W Fraser Symmans, William E Barlow

|Mar 18, 2020
Correction to: Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer.

Thomas L Gonzalez, Molly Hancock, Siqi Sun

|Feb 19, 2020
Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer.

Thomas L Gonzalez, Molly Hancock, Siqi Sun

Pageof 1